• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非那雄胺(保法止)治疗对脑和垂体5α-还原酶的年龄相关变化的影响。

Age-related changes in brain and pituitary 5 alpha-reductase with finasteride (Proscar) treatment.

作者信息

Lephart E D

机构信息

Department of Zoology, Brigham Young University, Provo, UT 84602, USA.

出版信息

Neurobiol Aging. 1995 Jul-Aug;16(4):647-50. doi: 10.1016/0197-4580(95)98115-5.

DOI:10.1016/0197-4580(95)98115-5
PMID:8544916
Abstract

Finasteride (Proscar), a 5 alpha-reductase inhibitor, was administered with or without 5 alpha-dihydrotestosterone (DHT) in juvenile (28), peripubertal (48), or young adult (68-day-old) male rats. Luteinizing hormone (LH) levels and ventral prostate (VP) weights monitored the efficacy of the treatments. For each postnatal day tested, LH hormone levels were not significantly altered by finasteride, suggesting that 5 alpha-reductase inhibition does not modulate LH in male rats using this protocol. Finasteride plus DHT treatment significantly decreased LH levels. Conversely, VP weights were significantly decreased in finasteride-treated animals while finasteride plus DHT treatment significantly increased VP values. Finasteride plus DHT treatment significantly decreased pituitary, but not brain, 5 alpha-reductase for each postnatal day tested. In finasteride-treated animals, hypothalamic and pituitary 5 alpha-reductase were significantly inhibited in young adult animals, whereas the activities were not altered in juvenile or peripubertal male rats. These data suggest that a different mechanism may regulate 5 alpha-reductase with the aging of the central nervous system and pituitary.

摘要

非那雄胺(保列治)是一种5α-还原酶抑制剂,在幼年(28日龄)、青春期前后(48日龄)或年轻成年(68日龄)雄性大鼠中,分别在给予或不给予5α-双氢睾酮(DHT)的情况下给药。通过监测黄体生成素(LH)水平和腹侧前列腺(VP)重量来评估治疗效果。对于所测试的每个出生后天数,非那雄胺对LH激素水平没有显著影响,这表明按照此方案,5α-还原酶抑制不会调节雄性大鼠的LH。非那雄胺加DHT治疗可显著降低LH水平。相反,非那雄胺治疗的动物VP重量显著降低,而非那雄胺加DHT治疗则显著增加VP值。对于所测试的每个出生后天数,非那雄胺加DHT治疗可显著降低垂体而非大脑的5α-还原酶。在非那雄胺治疗的动物中,年轻成年动物的下丘脑和垂体5α-还原酶受到显著抑制,而在幼年或青春期前后的雄性大鼠中,其活性未发生改变。这些数据表明,随着中枢神经系统和垂体的老化,可能存在不同的机制调节5α-还原酶。

相似文献

1
Age-related changes in brain and pituitary 5 alpha-reductase with finasteride (Proscar) treatment.非那雄胺(保法止)治疗对脑和垂体5α-还原酶的年龄相关变化的影响。
Neurobiol Aging. 1995 Jul-Aug;16(4):647-50. doi: 10.1016/0197-4580(95)98115-5.
2
Altered brain and pituitary androgen metabolism by prenatal, perinatal or pre- and postnatal finasteride, flutamide or dihydrotestosterone treatment in juvenile male rats.在幼年雄性大鼠中,通过产前、围产期或产前及产后使用非那雄胺、氟他胺或双氢睾酮治疗来改变大脑和垂体的雄激素代谢。
Prog Neuropsychopharmacol Biol Psychiatry. 1993 Nov;17(6):991-1003. doi: 10.1016/0278-5846(93)90026-o.
3
The action of 5 alpha-dihydrotestosterone and antiandrogens on the activities of 5 alpha-reductase and 3 alpha-hydroxysteroid dehydrogenase in the pituitary gland of gonadectomized rats.5α-双氢睾酮和抗雄激素对去势大鼠垂体中5α-还原酶和3α-羟基类固醇脱氢酶活性的作用。
J Steroid Biochem. 1982 Apr;16(4):545-52. doi: 10.1016/0022-4731(82)90077-2.
4
Morphological and hormonal changes in the ventral and dorsolateral prostatic lobes of rats treated with finasteride, a 5-alpha reductase inhibitor.用5-α还原酶抑制剂非那雄胺治疗的大鼠腹侧和背外侧前列腺叶的形态学和激素变化。
Prostate. 1998 May 15;35(3):157-64. doi: 10.1002/(sici)1097-0045(19980515)35:3<157::aid-pros1>3.0.co;2-e.
5
CGP 53153: a new potent inhibitor of 5alpha-reductase.CGP 53153:一种新型强效5α-还原酶抑制剂。
J Steroid Biochem Mol Biol. 1996 Feb;57(3-4):187-95. doi: 10.1016/0960-0760(95)00260-x.
6
Dihydrotestosterone and the concept of 5alpha-reductase inhibition in human benign prostatic hyperplasia.双氢睾酮与人类良性前列腺增生中5α-还原酶抑制的概念
Eur Urol. 2000 Apr;37(4):367-80. doi: 10.1159/000020181.
7
Inhibition of 5alpha-reductase in rat prostate reveals differential regulation of androgen-response gene expression by testosterone and dihydrotestosterone.抑制大鼠前列腺中的5α-还原酶可揭示睾酮和双氢睾酮对雄激素反应基因表达的差异调节。
Gene Expr. 2001;9(4-5):183-94. doi: 10.3727/000000001783992551.
8
Comparison of the pharmacological effects of a novel selective androgen receptor modulator, the 5alpha-reductase inhibitor finasteride, and the antiandrogen hydroxyflutamide in intact rats: new approach for benign prostate hyperplasia.新型选择性雄激素受体调节剂、5α-还原酶抑制剂非那雄胺及抗雄激素药物羟基氟他胺在成年大鼠体内的药理作用比较:良性前列腺增生的新研究方法
Endocrinology. 2004 Dec;145(12):5420-8. doi: 10.1210/en.2004-0627. Epub 2004 Aug 12.
9
Feedback regulation of gonadotropins by androgens in rats: is 5 alpha-reduction involved?雄激素对大鼠促性腺激素的反馈调节:是否涉及5α-还原作用?
J Steroid Biochem Mol Biol. 1995 Jan;52(1):105-12. doi: 10.1016/0960-0760(94)00150-k.
10
Androgen metabolism in the prostate of the finasteride-treated, adult rat: a possible explanation for the differential action of testosterone and 5 alpha-dihydrotestosterone during development of the male urogenital tract.非那雄胺治疗的成年大鼠前列腺中的雄激素代谢:对雄性泌尿生殖道发育过程中睾酮和5α-二氢睾酮差异作用的一种可能解释。
Endocrinology. 1997 Mar;138(3):871-7. doi: 10.1210/endo.138.3.5009.

引用本文的文献

1
Dihydrotestosterone: Biochemistry, Physiology, and Clinical Implications of Elevated Blood Levels.双氢睾酮:血液水平升高的生物化学、生理学及临床意义
Endocr Rev. 2017 Jun 1;38(3):220-254. doi: 10.1210/er.2016-1067.
2
Investigation of the Plausibility of 5-Alpha-Reductase Inhibitor Syndrome.5α-还原酶抑制剂综合征合理性的调查。
Skin Appendage Disord. 2017 Jan;2(3-4):120-129. doi: 10.1159/000450617. Epub 2016 Sep 23.
3
Impact of alpha blockers, 5-alpha reductase inhibitors and combination therapy on sexual function.α受体阻滞剂、5-α还原酶抑制剂及联合治疗对性功能的影响。
Curr Urol Rep. 2014 Oct;15(10):441. doi: 10.1007/s11934-014-0441-2.
4
Finasteride induced depression: a prospective study.非那雄胺所致抑郁:一项前瞻性研究。
BMC Clin Pharmacol. 2006 Oct 7;6:7. doi: 10.1186/1472-6904-6-7.
5
A new look at the 5alpha-reductase inhibitor finasteride.对5α-还原酶抑制剂非那雄胺的新审视。
CNS Drug Rev. 2006 Spring;12(1):53-76. doi: 10.1111/j.1527-3458.2006.00053.x.